Literature DB >> 3585733

Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat.

J C Fleishaker, N Desai, P J McNamara.   

Abstract

The factors that affect M/P (milk-to-plasma) ratios of several compounds were assessed in vitro using samples collected from four healthy lactating women. Three drugs were studied: diazepam, phenytoin, and propranolol. Serum and skim milk protein binding were determined by equilibrium dialysis at 37 degrees C. Skim-to-whole milk concentration ratios (S/M) were determined after incubation of whole milk at 37 degrees C for 1 h. Free fractions in serum and skim milk, respectively, were 0.013 and 0.334 for diazepam, 0.142 and 0.584 for phenytoin, and 0.107 and 0.699 for propranolol. The S/M values were 0.220, 0.727, and 0.610 for diazepam, phenytoin, and propranolol, respectively. An equation was derived which relates M/P to milk and plasma pH, unbound fractions of drug in skim milk and serum, and S/M. The M/P ratios calculated from in vitro data agreed with published in vivo M/P ratios. The results indicated that milk protein binding and fat partitioning can make a substantial contribution in determining M/P, and predictions of M/P made without considering these factors may be misleading.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585733     DOI: 10.1002/jps.2600760302

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

Review 1.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.

Authors:  Lipeng Wang; Markos Leggas; Mamta Goswami; Philip E Empey; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

3.  Excretion of tiapamil in breast milk.

Authors:  D Hartmann; N O Lunell; G Friedrich; A Rane
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 4.  Biological barriers, and the influence of protein binding on the passage of drugs across them.

Authors:  Karolina Wanat
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

Review 5.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

6.  Daily rhythms in blood and milk lead toxicokinetics following intravenous administration of lead acetate to dairy cows in summer.

Authors:  S E Valtorta; M C Scaglione; P Acosta; J E Coronel; H R Beldomenico; J C Boggio
Journal:  Int J Biometeorol       Date:  2005-09-21       Impact factor: 3.787

7.  An in vitro technique for the rapid determination of drug entry into breast milk.

Authors:  L J Notarianni; D Belk; S A Aird; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

8.  Binding of drugs in milk: the role of casein in milk protein binding.

Authors:  T Stebler; T W Guentert
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

Review 9.  Managing epilepsy in women of childbearing age.

Authors:  Pamela M Crawford
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk.

Authors:  C Y Oo; R J Kuhn; N Desai; C E Wright; P J McNamara
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.